Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-14 3:40 pm Sale | 2025-03-31 | 13G | UBS Group AG UBS | NORGES BANK | 139,886,962 4.000% | -36,137,490 (-20.53%) | Filing History |
| 2025-02-10 10:59 am Purchase | 2024-12-31 | 13G | Vipshop Holdings Limited VIPS | UBS Group AG | 15,943,270 18.300% | 14,338,948 (+893.77%) | Filing History |
| 2025-02-10 10:42 am Sale | 2024-12-31 | 13G | PIMCO Access Income Fund PAXS | UBS Group AG | 2,233,985 5.100% | -701,709 (-23.90%) | Filing History |
| 2025-02-10 09:26 am Purchase | 2024-12-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 16,774,708 5.100% | 16,774,708 (New Position) | Filing History |
| 2025-02-10 09:13 am Sale | 2024-12-31 | 13G | Liberty Broadband Corporation LBRDK | UBS Group AG | 0 0.000% | -7,781,165 (Position Closed) | Filing History |
| 2025-02-10 08:59 am Sale | 2024-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | UBS Group AG | 0 0.000% | -21,491,881 (Position Closed) | Filing History |
| 2025-02-10 08:33 am Purchase | 2024-12-31 | 13G | Color Star Technology Co., Ltd. ADD | UBS Group AG | 37,162 7.100% | 37,162 (New Position) | Filing History |
| 2024-11-08 12:14 pm Purchase | 2024-09-30 | 13G | UBS Group AG UBS | NORGES BANK | 176,024,452 5.080% | 176,024,452 (New Position) | Filing History |
| 2024-11-06 12:04 pm Purchase | 2024-09-30 | 13G | Infinera Corporation INFN | UBS Group AG | 14,484,028 6.100% | 14,484,028 (New Position) | Filing History |
| 2024-11-04 10:49 am Purchase | 2024-09-30 | 13G | Rapid7, Inc. RPD | UBS Group AG | 3,941,537 6.300% | 3,941,537 (New Position) | Filing History |
| 2024-11-01 09:00 am Purchase | 2024-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 750,319 46.900% | 20,547 (+2.82%) | Filing History |
| 2024-10-31 10:43 am Purchase | 2024-09-30 | 13G | Thornburg Income Builder Opportunities Trust TBLD | UBS Group AG | 1,803,654 5.600% | 1,803,654 (New Position) | Filing History |
| 2024-10-30 3:18 pm Sale | 2024-09-30 | 13G | Cohen & Steers Limited Duration Preferred and Income Fund, Inc. LDP | UBS Group AG | 0 0.000% | -1,474,839 (Position Closed) | Filing History |
| 2024-10-30 11:30 am Purchase | 2024-09-30 | 13G | Liberty Broadband Corporation LBRDK | UBS Group AG | 7,781,165 6.400% | 7,781,165 (New Position) | Filing History |
| 2024-10-30 11:04 am Purchase | 2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX | UBS Group AG | 21,491,881 6.900% | 21,491,881 (New Position) | Filing History |
| 2024-08-08 12:55 pm Sale | 2024-06-30 | 13G | Sight Sciences, Inc. SGHT | UBS Group AG | 0 0.000% | -2,879,863 (Position Closed) | Filing History |
| 2024-08-08 12:48 pm Sale | 2024-06-30 | 13G | The Marcus Corporation MCS | UBS Group AG | 0 0.000% | -1,299,728 (Position Closed) | Filing History |
| 2024-08-08 11:36 am Unchanged | 2024-06-30 | 13G | ASLAN Pharmaceuticals Limited ASLN | UBS Group AG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-06-28 09:22 am Unchanged | 2024-06-28 | 13G | The Gabelli Dividend & Income Trust GDV | UBS Group AG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-06-28 09:11 am Unchanged | 2024-06-28 | 13G | The Gabelli Multimedia Trust Inc. GGT | UBS Group AG | 0 0.000% | 0 (Unchanged) | Filing History |